Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Membrane Protective Technologies Inc. maintains a patent portfolio within the Biotechnology & Pharmaceuticals technology area. There are currently 2 pending office actions that require a response. The presence of 2 pending office actions indicates the current scale of the company's engagement with the patent office.
The workload is distributed across 2 distinct examiners and 2 distinct art units. Because the company is dealing with 2 distinct art units, the legal strategy must be adaptable to different technical standards and examination cultures. The presence of 2 distinct examiners means that the company cannot rely on an individual relationship or point of contact to resolve its 2 pending office actions.
VAN BUREN, LAUREN K is identified as the busiest examiner, currently overseeing 1 busiest examiner pending office action. This specific action is part of the total workload the company must address. Practitioners should note that while VAN BUREN, LAUREN K is the busiest, the workload is distributed, as the 1 busiest examiner pending office action is joined by a separate action held by a different examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VAN BUREN, LAUREN K | 1 | 39.8% | +58.1% |
| CORDAS, EMILY ANN | 1 | 50.8% | +57.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17438830 | Methods and Systems for Protective Supplementation During Temperature Depression | VAN BUREN, LAUREN K | 78d |
| 16766254 | Methods and Systems for Synergistic Continuity Approaches to Treatment and Preservation of Biological Cells | CORDAS, EMILY ANN | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17438830 | Methods and Systems for Protective Supplementation During Temperature Depression | VAN BUREN, LAUREN K | 1638 | §103 | Final Rejection | 78d | Pending | Sep 13, 2021 |
| 16766254 | Methods and Systems for Synergistic Continuity Approaches to Treatment and Preservation of Biological Cells | CORDAS, EMILY ANN | 1632 | §103 | Non-Final OA | — | Pending | May 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial